Global Monoclonal Antibodies (mAbs) Market 2020-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Region: Trend Forecast and Growth Opportunity

December 2021 | 165 pages | ID: GA178AD5EB97EN
GMD Research

Abstracts

Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies.

Highlighted with 83 tables and 84 figures, this 165-page report “Global Monoclonal Antibodies (mAbs) Market 2020-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global monoclonal antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global monoclonal antibodies market in every aspect of the classification from perspectives of Source, Category, Production Type, Application, End User, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Human
• Humanized
• Chimeric
• Murine

Based on Category, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Branded mAbs
• Biosimilar mAbs

Based on Production Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• In Vitro Production
• In Vivo Production

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Cancer
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Ovarian Cancer
• Other Cancer Types
• Autoimmune Diseases
• Inflammatory Diseases
• Infectious Diseases
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Hospitals
• Research Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Source, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

AbbVie, Inc.

Amgen Inc.

AstraZeneca plc

Bayer AG

Bristol-Myers Squibb Company

Eli Lilly

F. Hoffmann-La Roche Ltd.

GlaxoSmithKline Plc

Johnson & Johnson

Merck & Co., Inc.

Mylan N.V

Norvatis AG

Pfizer

Sanofi S.A.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY SOURCE

3.1 Market Overview by Source
3.2 Human
3.3 Humanized
3.4 Chimeric
3.5 Murine

4 SEGMENTATION OF GLOBAL MARKET BY CATEGORY

4.1 Market Overview by Category
4.2 Branded mAbs
4.3 Biosimilar mAbs

5 SEGMENTATION OF GLOBAL MARKET BY PRODUCTION TYPE

5.1 Market Overview by Production Type
5.2 In Vitro Production
5.3 In Vivo Production

6 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Cancer
  6.2.1 Breast Cancer
  6.2.2 Colorectal Cancer
  6.2.3 Lung Cancer
  6.2.4 Ovarian Cancer
  6.2.5 Other Cancer Types
6.3 Autoimmune Diseases
6.4 Inflammatory Diseases
6.5 Infectious Diseases
6.6 Other Applications

7 SEGMENTATION OF GLOBAL MARKET BY END USER

7.1 Market Overview by End User
7.2 Hospitals
7.3 Research Institutes
7.4 Other End Users

8 SEGMENTATION OF GLOBAL MARKET BY REGION

8.1 Geographic Market Overview 2019-2030
8.2 North America Market 2019-2030 by Country
  8.2.1 Overview of North America Market
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 European Market 2019-2030 by Country
  8.3.1 Overview of European Market
  8.3.2 Germany
  8.3.3 U.K.
  8.3.4 France
  8.3.5 Spain
  8.3.6 Italy
  8.3.7 Russia
  8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2019-2030 by Country
  8.4.1 Overview of Asia-Pacific Market
  8.4.2 Japan
  8.4.3 China
  8.4.4 Australia
  8.4.5 India
  8.4.6 South Korea
  8.4.7 Rest of APAC Region
8.5 South America Market 2019-2030 by Country
  8.5.1 Argentina
  8.5.2 Brazil
  8.5.3 Chile
  8.5.4 Rest of South America Market
8.6 MEA Market 2019-2030 by Country
  8.6.1 UAE
  8.6.2 Saudi Arabia
  8.6.3 South Africa
  8.6.4 Other National Markets

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories
AbbVie, Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V
Norvatis AG
Pfizer
Sanofi S.A.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Monoclonal Antibodies Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Global Monoclonal Antibodies Market
Table 5. Global Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 6. Global Monoclonal Antibodies Market by Category, 2019-2030, $ bn
Table 7. Global Monoclonal Antibodies Market by Production Type, 2019-2030, $ bn
Table 8. Global Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 9. Global Monoclonal Antibodies Market: Cancer Therapy by Type, 2019-2030, $ bn
Table 10. Global Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 11. Global Monoclonal Antibodies Market by Region, 2019-2030, $ bn
Table 12. Leading National Monoclonal Antibodies Market, 2019 and 2030F, $ bn
Table 13. North America Monoclonal Antibodies Market by Country, 2019-2030, $ bn
Table 14. U.S. Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 15. U.S. Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 16. U.S. Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 17. Canada Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 18. Canada Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 19. Canada Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 20. Mexico Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 21. Mexico Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 22. Mexico Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 23. Europe Monoclonal Antibodies Market by Country, 2019-2030, $ bn
Table 24. Germany Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 25. Germany Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 26. Germany Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 27. U.K. Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 28. U.K. Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 29. U.K. Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 30. France Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 31. France Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 32. France Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 33. Spain Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 34. Spain Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 35. Spain Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 36. Italy Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 37. Italy Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 38. Italy Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 39. Russia Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 40. Russia Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 41. Russia Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 42. Monoclonal Antibodies Market in Rest of Europe by Country, 2019-2030, $ bn
Table 43. APAC Monoclonal Antibodies Market by Country, 2019-2030, $ bn
Table 44. Japan Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 45. Japan Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 46. Japan Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 47. China Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 48. China Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 49. China Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 50. Australia Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 51. Australia Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 52. Australia Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 53. India Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 54. India Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 55. India Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 56. South Korea Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 57. South Korea Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 58. South Korea Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 59. Monoclonal Antibodies Market in Rest of APAC by Country/Region, 2019-2030, $ bn
Table 60. South America Monoclonal Antibodies Market by Country, 2019-2030, $ bn
Table 61. Argentina Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 62. Argentina Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 63. Argentina Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 64. Brazil Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 65. Brazil Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 66. Brazil Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 67. Chile Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 68. Chile Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 69. Chile Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 70. MEA Monoclonal Antibodies Market by Country, 2019-2030, $ bn
Table 71. UAE Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 72. UAE Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 73. UAE Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 74. Saudi Arabia Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 75. Saudi Arabia Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 76. Saudi Arabia Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 77. South Africa Monoclonal Antibodies Market by Source, 2019-2030, $ bn
Table 78. South Africa Monoclonal Antibodies Market by Application, 2019-2030, $ bn
Table 79. South Africa Monoclonal Antibodies Market by End User, 2019-2030, $ bn
Table 80. Abbott Laboratories: Company Snapshot
Table 81. Abbott Laboratories: Business Segmentation
Table 82. Abbott Laboratories: Product Portfolio
Table 83. Abbott Laboratories: Revenue, 2018-2020, $ bn

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. Global Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Monoclonal Antibodies Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Global Monoclonal Antibodies Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Monoclonal Antibodies Market
Figure 12. Breakdown of Global Monoclonal Antibodies Market by Source, 2019-2030, % of Revenue
Figure 13. Global Addressable Market Cap in 2021-2030 by Source, Value ($ bn) and Share (%)
Figure 14. Global Monoclonal Antibodies Market by Source: Human, 2019-2030, $ bn
Figure 15. Global Monoclonal Antibodies Market by Source: Humanized, 2019-2030, $ bn
Figure 16. Global Monoclonal Antibodies Market by Source: Chimeric, 2019-2030, $ bn
Figure 17. Global Monoclonal Antibodies Market by Source: Murine, 2019-2030, $ bn
Figure 18. Breakdown of Global Monoclonal Antibodies Market by Category, 2019-2030, % of Sales Revenue
Figure 19. Global Addressable Market Cap in 2021-2030 by Category, Value ($ bn) and Share (%)
Figure 20. Global Monoclonal Antibodies Market by Category: Branded mAbs, 2019-2030, $ bn
Figure 21. Global Monoclonal Antibodies Market by Category: Biosimilar mAbs, 2019-2030, $ bn
Figure 22. Breakdown of Global Monoclonal Antibodies Market by Production Type, 2019-2030, % of Sales Revenue
Figure 23. Global Addressable Market Cap in 2021-2030 by Production Type, Value ($ bn) and Share (%)
Figure 24. Global Monoclonal Antibodies Market by Production Type: In Vitro Production, 2019-2030, $ bn
Figure 25. Global Monoclonal Antibodies Market by Production Type: In Vivo Production, 2019-2030, $ bn
Figure 26. Breakdown of Global Monoclonal Antibodies Market by Application, 2019-2030, % of Revenue
Figure 27. Global Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%)
Figure 28. Global Monoclonal Antibodies Market by Application: Cancer, 2019-2030, $ bn
Figure 29. Global Monoclonal Antibodies Market by Cancer Type: Breast Cancer, 2019-2030, $ bn
Figure 30. Global Monoclonal Antibodies Market by Cancer Type: Colorectal Cancer, 2019-2030, $ bn
Figure 31. Global Monoclonal Antibodies Market by Cancer Type: Lung Cancer, 2019-2030, $ bn
Figure 32. Global Monoclonal Antibodies Market by Cancer Type: Ovarian Cancer, 2019-2030, $ bn
Figure 33. Global Monoclonal Antibodies Market by Cancer Type: Other Cancer Types, 2019-2030, $ bn
Figure 34. Global Monoclonal Antibodies Market by Application: Autoimmune Diseases, 2019-2030, $ bn
Figure 35. Global Monoclonal Antibodies Market by Application: Inflammatory Diseases, 2019-2030, $ bn
Figure 36. Global Monoclonal Antibodies Market by Application: Infectious Diseases, 2019-2030, $ bn
Figure 37. Global Monoclonal Antibodies Market by Application: Other Applications, 2019-2030, $ bn
Figure 38. Breakdown of Global Monoclonal Antibodies Market by End User, 2019-2030, % of Revenue
Figure 39. Global Addressable Market Cap in 2021-2030 by End User, Value ($ bn) and Share (%)
Figure 40. Global Monoclonal Antibodies Market by End User: Hospitals, 2019-2030, $ bn
Figure 41. Global Monoclonal Antibodies Market by End User: Research Institutes, 2019-2030, $ bn
Figure 42. Global Monoclonal Antibodies Market by End User: Other End Users, 2019-2030, $ bn
Figure 43. Global Market Snapshot by Region
Figure 44. Geographic Spread of Worldwide Monoclonal Antibodies Market, 2019-2030, % of Sales Revenue
Figure 45. Global Addressable Market Cap in 2021-2030 by Region, Value ($ bn) and Share (%)
Figure 46. North American Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 47. Breakdown of North America Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue
Figure 48. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 49. U.S. Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 50. Canada Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 51. Monoclonal Antibodies Market in Mexico, 2019-2030, $ bn
Figure 52. European Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 53. Breakdown of European Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue
Figure 54. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 55. Monoclonal Antibodies Market in Germany, 2019-2030, $ bn
Figure 56. Monoclonal Antibodies Market in U.K., 2019-2030, $ bn
Figure 57. Monoclonal Antibodies Market in France, 2019-2030, $ bn
Figure 58. Monoclonal Antibodies Market in Spain, 2019-2030, $ bn
Figure 59. Monoclonal Antibodies Market in Italy, 2019-2030, $ bn
Figure 60. Monoclonal Antibodies Market in Russia, 2019-2030, $ bn
Figure 61. Monoclonal Antibodies Market in Rest of Europe, 2019-2030, $ bn
Figure 62. Asia-Pacific Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 63. Breakdown of APAC Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue
Figure 64. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 65. Monoclonal Antibodies Market in Japan, 2019-2030, $ bn
Figure 66. Monoclonal Antibodies Market in China, 2019-2030, $ bn
Figure 67. Monoclonal Antibodies Market in Australia, 2019-2030, $ bn
Figure 68. Monoclonal Antibodies Market in India, 2019-2030, $ bn
Figure 69. Monoclonal Antibodies Market in South Korea, 2019-2030, $ bn
Figure 70. Monoclonal Antibodies Market in Rest of APAC, 2019-2030, $ bn
Figure 71. South America Monoclonal Antibodies Market, 2019-2030, $ bn
Figure 72. Breakdown of South America Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue
Figure 73. Contribution to South America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 74. Monoclonal Antibodies Market in Argentina, 2019-2030, $ bn
Figure 75. Monoclonal Antibodies Market in Brazil, 2019-2030, $ bn
Figure 76. Monoclonal Antibodies Market in Chile, 2019-2030, $ bn
Figure 77. Monoclonal Antibodies Market in Rest of South America, 2019-2030, $ bn
Figure 78. Monoclonal Antibodies Market in Middle East and Africa (MEA), 2019-2030, $ bn
Figure 79. Breakdown of MEA Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue
Figure 80. Contribution to MEA 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 81. Monoclonal Antibodies Market in UAE, 2019-2030, $ bn
Figure 82. Monoclonal Antibodies Market in Saudi Arabia, 2019-2030, $ bn
Figure 83. Monoclonal Antibodies Market in South Africa, 2019-2030, $ bn
Figure 84. Growth Stage of Global Monoclonal Antibodies Industry over the Forecast Period